Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendation

Gynecol Oncol. 2021 Dec;163(3):605-613. doi: 10.1016/j.ygyno.2021.10.003. Epub 2021 Oct 20.

Authors

N S Horowitz¹, R N Eskander², M R Adelman³, W Burke⁴

Affiliations

¹ Brigham & Women's Hospital/Dana Farber Cancer Institute, Boston, MA, USA. Electronic address: nhorowitz@partners.org.
² University of California, San Diego, Moores Cancer Center, La Jolla, CA, USA.
³ University of Utah, Salt Lake City, UT, USA.
⁴ Stony Brook Medicine, Long Island, NY, USA.

PMID: 34686354
DOI: 10.1016/j.ygyno.2021.10.003

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Evidence-Based Medicine
Female
Gestational Trophoblastic Disease / diagnosis*
Gestational Trophoblastic Disease / epidemiology
Gestational Trophoblastic Disease / therapy*
Humans
Practice Guidelines as Topic
Pregnancy